Bluebird gene therapy granted EMA accelerated assessment status
Bluebird Bio’s beta thalassemia gene therapy LentiGlobin has been accepted into the EMA’s priority review programme, PRIME.
Archives for September 26, 2016
Gates Foundation grant aims to reduce cost of manufacturing rotavirus vaccine
Fixed-bed, high cell density bioreactors and a naturally occurring attenuated viral strain will be used by Batavia Biosciences in an attempt to produce an affordable rotavirus vaccine.
UPDATE
Regeneron thanks Abec for helping it avoid "gremlins" during bio plant set-up
Abec has completed work on Regeneron’s biologics facility in Ireland just 28 months after it was hired to kit out the repurposed computer plant.